Arbutus CFO Secures Massive RSU/Option Grant Amid Stock Volatility — Insider Confidence Signals Hope for Hepatitis B Pipeline
Arbutus Biopharma insiders, including CFO Nguyen Tuan, grant significant RSUs and options—showing confidence amid a patent setback and volatile stock, signaling potential upside for investors.
3 minutes to read